References
- Davenport A. Anionic bases for continuous forms of renal replacement therapy (CRRT) in the ICU. Intensive Care Med. 1999; 25: 1209–1211, [PUBMED], [INFOTRIEVE], [CSA]
- Heering P., Ivens K., Thumer O., Morgera S., Heintzen M., Passlik‐Deerjen J., Willers R., Strauer B. F., Grabensee B. The use of different buffers during continuous hemofiltration in critically ill patients with acute renal failure. Intensive Care Med. 1999; 25: 1244–1251, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Heering P., Ivens K., Thumer O., Brause M., Grabensee B. Acid–base balance and substitution fluid during continuous hemofiltration. Kidney Int. 1999; 56(Suppl 72)S37–S40, [CSA]
- Davenport A., Will E. J., Davison A. M. Hyperlactatemia and metabolic acidosis during hemofiltration using lactate buffered fluids. Nephron 1991; 59: 461–465, [PUBMED], [INFOTRIEVE]
- Thomas A. N., Guy J. M., Kishen R., Bowles B. M.J., Vadgama P. Comparison of lactate and bicarbonate buffered hemofiltration fluids: use in critically ill patients. Nephrol. Dial. Transplant. 1997; 12: 1212–1217, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Davenport A., Worth D. P., Will E. J. Hypochloremic alkalosis after high flux continuous hemofiltration and continuous arterio‐venous hemofiltration with dialysis. Lancet 1988; 1: 658, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Bone R. C., Balk R. A., Cerra F. B., Dellinger R. P., Fein A. M., Knaus W. A., Schein R. M., Sibbald W. J. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies. Chest 1992; 101: 1644–1655, [PUBMED], [INFOTRIEVE]
- Morimatsu H., Uchino S., Bellomo R., Ronco C. Continuous renal replacement therapy: does technique influence azotemic control?. Ren. Fail. 2002; 24: 645–653, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Tan H. K., Bellomo R., M'Pisi D. A., Ronco C. Phosphatemic control during acute renal failure: intermittent hemodialysis versus continuous. Int. J. Artif. Organs 2001; 24: 186–191, [PUBMED], [INFOTRIEVE], [CSA]